QGEN
Qiagen N.V. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +30.0% ·
net new positions +20.0%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 24.44M | New | $972.19M | 0.2% | New | 1 | SEC ↗ ×9 |
| 2 | T. Rowe Price ✦ | 4.47M | +3030.9% | $179.50M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 3.36M | New | $133.47M | 0.0% | New | 1 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passive) | 2.21M | New | $88.89M | 0.0% | New | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 1.11M | -22.5% | $44.01M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (passive) | 1.09M | New | $43.88M | 0.0% | New | 1 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 850.44K | New | $34.15M | 0.0% | New | 1 | SEC ↗ ×2 |
| 8 | Point72 Asset Management ✦ | 733.59K | New | $29.45M | 0.1% | New | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 511.15K | New | $20.52M | 0.0% | New | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 178.43K | New | $7.16M | 0.0% | New | 1 | SEC ↗ ×3 |
| 11 | Millennium Management ✦ | 137.17K | New | $5.51M | 0.0% | New | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 37.86K | New | $1.52M | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Wellington Management | $972.19M | 0.2% |
| Norges Bank | $133.47M | 0.0% |
| State Street Global Advisors | $88.89M | 0.0% |
| Geode Capital Management | $43.88M | 0.0% |
| Citadel Advisors | $34.15M | 0.0% |
| Point72 Asset Management | $29.45M | 0.1% |
| Two Sigma Investments | $20.52M | 0.0% |
| AQR Capital Management | $7.16M | 0.0% |
| Millennium Management | $5.51M | 0.0% |
| D. E. Shaw & Co. | $1.52M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 7 holders, 1.07M shares, $43.54M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.